This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Nov 2;75(18 Suppl 1):S9-15.

doi: 10.1212/WNL.0b013e3181fb3628.

Current understanding and management of Parkinson disease: five new things

James F Morley¹, Howard I Hurtig

Affiliations

PMID: 21041778
DOI: 10.1212/WNL.0b013e3181fb3628

Review

Current understanding and management of Parkinson disease: five new things

James F Morley et al. Neurology. 2010.

. 2010 Nov 2;75(18 Suppl 1):S9-15.

doi: 10.1212/WNL.0b013e3181fb3628.

Authors

James F Morley¹, Howard I Hurtig

Affiliation

¹ Parkinson's Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA 19107, USA.

PMID: 21041778
DOI: 10.1212/WNL.0b013e3181fb3628

No abstract available

PubMed Disclaimer

Similar articles

What is deep brain stimulation for Parkinson's disease?
[No authors listed] [No authors listed] J Pract Nurs. 2009 Summer;59(2):14-5. J Pract Nurs. 2009. PMID: 19719000 No abstract available.
After the diagnosis: living with Parkinson's. There's no cure for Parkinson's disease, but new treatments can ease the symptoms and prolong independence.
[No authors listed] [No authors listed] Harv Womens Health Watch. 2006 Jun;13(10):2-4. Harv Womens Health Watch. 2006. PMID: 16841381 No abstract available.
Is deep brain stimulation neuroprotective if applied early in the course of PD?
Charles PD, Gill CE, Davis TL, Konrad PE, Benabid AL. Charles PD, et al. Nat Clin Pract Neurol. 2008 Aug;4(8):424-6. doi: 10.1038/ncpneuro0848. Epub 2008 Jul 1. Nat Clin Pract Neurol. 2008. PMID: 18594505 Review. No abstract available.
Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.
Kopell BH, Rezai AR, Chang JW, Vitek JL. Kopell BH, et al. Mov Disord. 2006 Jun;21 Suppl 14:S238-46. doi: 10.1002/mds.20958. Mov Disord. 2006. PMID: 16810674
Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
Olanow CW. Olanow CW. Neurology. 2009 Feb 17;72(7 Suppl):S59-64. doi: 10.1212/WNL.0b013e318199068b. Neurology. 2009. PMID: 19221316 Review.

See all similar articles

Cited by

Purinergic Signaling and its Role in the Stem Cell Differentiation.
Zaib S, Areeba, Khan I. Zaib S, et al. Mini Rev Med Chem. 2024;24(8):863-883. doi: 10.2174/0113895575261206231003151416. Mini Rev Med Chem. 2024. PMID: 37828668 Review.
Role of P11 through serotonergic and glutamatergic pathways in LID.
Noori A, Farhadi K, Mohtasham Kia Y, Hosseini N, Mehrabi S. Noori A, et al. Mol Biol Rep. 2023 May;50(5):4535-4549. doi: 10.1007/s11033-023-08326-3. Epub 2023 Feb 28. Mol Biol Rep. 2023. PMID: 36853472 Review.
Non-motor symptoms are associated with REM sleep behavior disorder in Parkinson's disease: a systematic review and meta-analysis.
Xie D, Shen Q, Zhou J, Xu Y. Xie D, et al. Neurol Sci. 2021 Jan;42(1):47-60. doi: 10.1007/s10072-020-04769-9. Epub 2020 Oct 6. Neurol Sci. 2021. PMID: 33025325
Rafts, Nanoparticles and Neural Disease.
Gulati V, Wallace R. Gulati V, et al. Nanomaterials (Basel). 2012 Aug 6;2(3):217-250. doi: 10.3390/nano2030217. Nanomaterials (Basel). 2012. PMID: 28348305 Free PMC article. Review.
Protection of dopaminergic neurons in a mouse model of Parkinson's disease by a physically-modified saline containing charge-stabilized nanobubbles.
Khasnavis S, Roy A, Ghosh S, Watson R, Pahan K. Khasnavis S, et al. J Neuroimmune Pharmacol. 2014 Mar;9(2):218-32. doi: 10.1007/s11481-013-9503-3. J Neuroimmune Pharmacol. 2014. PMID: 24122363

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information